493 related articles for article (PubMed ID: 17953284)
1. [Pyoderma gangrenosum: case series].
Richetta AG; Maiani E; Carboni V; Carlomagno V; Cimillo M; Mattozzi C; Calvieri S
Clin Ter; 2007; 158(4):325-9. PubMed ID: 17953284
[TBL] [Abstract][Full Text] [Related]
2. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
3. Pyoderma gangrenosum associated with hidradenitis suppurativa.
Ah-Weng A; Langtry JA; Velangi S; Evans CD; Douglas WS
Clin Exp Dermatol; 2005 Nov; 30(6):669-71. PubMed ID: 16197385
[TBL] [Abstract][Full Text] [Related]
4. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease.
Regueiro M; Valentine J; Plevy S; Fleisher MR; Lichtenstein GR
Am J Gastroenterol; 2003 Aug; 98(8):1821-6. PubMed ID: 12907338
[TBL] [Abstract][Full Text] [Related]
5. Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.
Kouklakis G; Moschos J; Leontiadis GI; Kadis S; Mpoumponaris A; Molyvas E; Minopoulos GI
Rom J Gastroenterol; 2005 Dec; 14(4):401-3. PubMed ID: 16400359
[TBL] [Abstract][Full Text] [Related]
6. A case of refractory pyoderma gangrenosum treated with a combination of Apligraf and systemic immunosuppressive agents.
Duchini G; Itin P; Arnold A
Adv Skin Wound Care; 2011 May; 24(5):217-20. PubMed ID: 21505282
[TBL] [Abstract][Full Text] [Related]
7. Pyoderma gangraenosum.
Wollina U; Haroske G
Curr Opin Rheumatol; 2011 Jan; 23(1):50-6. PubMed ID: 21037478
[TBL] [Abstract][Full Text] [Related]
8. Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis. Case report and literature review.
Juillerat P; Christen-Zäch S; Troillet FX; Gallot-Lavallée S; Pannizzon RG; Michetti P
Dermatology; 2007; 215(3):245-51. PubMed ID: 17823524
[TBL] [Abstract][Full Text] [Related]
9. Pyoderma gangrenosum--a review.
Wollina U
Orphanet J Rare Dis; 2007 Apr; 2():19. PubMed ID: 17433111
[TBL] [Abstract][Full Text] [Related]
10. Improvement of idiopathic pyoderma gangrenosum during treatment with anti-tumor necrosis factor alfa monoclonal antibody.
Dini V; Romanelli M; Bertone M; Talarico S; Bombardieri S; Barachini P
Int J Low Extrem Wounds; 2007 Jun; 6(2):108-13. PubMed ID: 17558009
[TBL] [Abstract][Full Text] [Related]
11. Management of peristomal pyoderma gangrenosum.
Kiran RP; O'Brien-Ermlich B; Achkar JP; Fazio VW; Delaney CP
Dis Colon Rectum; 2005 Jul; 48(7):1397-403. PubMed ID: 15868233
[TBL] [Abstract][Full Text] [Related]
12. Pyoderma gangrenosum.
Blitz NM; Rudikoff D
Mt Sinai J Med; 2001; 68(4-5):287-97. PubMed ID: 11514916
[TBL] [Abstract][Full Text] [Related]
13. Pyoderma gangrenosum: an updated review.
Ruocco E; Sangiuliano S; Gravina AG; Miranda A; Nicoletti G
J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1008-17. PubMed ID: 19470075
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic hotline. Infliximab for treatment of resistant pyoderma gangrenosum associated with ulcerative colitis and psoriasis. A case report.
Baglieri F; Scuderi G
Dermatol Ther; 2010; 23(5):541-3. PubMed ID: 20868408
[TBL] [Abstract][Full Text] [Related]
15. Pyoderma gangrenosum.
Conrad C; Trüeb RM
J Dtsch Dermatol Ges; 2005 May; 3(5):334-42. PubMed ID: 16372799
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of Pyoderma gangrenosum associated with Crohn's disease.
Zaccagna A; Bertone A; Puiatti P; Picciotto F; Sprujevnik T; Santucci R; Rossini FP
Eur J Dermatol; 2003; 13(3):258-60. PubMed ID: 12804985
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous manifestations in inflammatory bowel diseases: eight cases of psoriasis induced by anti-tumor-necrosis-factor antibody therapy.
Passarini B; Infusino SD; Barbieri E; Varotti E; Gionchetti P; Rizzello F; Morselli C; Tambasco R; Campieri M
Dermatology; 2007; 215(4):295-300. PubMed ID: 17911986
[TBL] [Abstract][Full Text] [Related]
18. Neutrophilic dermatoses: a review of current treatment options.
Cohen PR
Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
[TBL] [Abstract][Full Text] [Related]
19. Therapy Insight: pyoderma gangrenosum-old disease, new management.
Campbell S; Cripps S; Jewell DP
Nat Clin Pract Gastroenterol Hepatol; 2005 Dec; 2(12):587-94. PubMed ID: 16327838
[TBL] [Abstract][Full Text] [Related]
20. Pyoderma gangrenosum: a report of 44 cases with follow-up.
von den Driesch P
Br J Dermatol; 1997 Dec; 137(6):1000-5. PubMed ID: 9470924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
